Fin|Tech|Bio: The Future of Data and Cross-Sector Synergies
Fin|Tech|Bio returns to Level39, in partnership with Canary Wharf Group Life Sciences, with another anticipated sell-out evening exploring the ideas, partnerships and technologies shaping the future at the intersection of finance, technology, life sciences and healthcare.
Data is redefining innovation across sectors. Whether enabling personalised medicine or powering precision finance, access to high-quality, trusted and ethical data is becoming critical to progress.
But unlocking its full potential requires collaboration across industries, new approaches to governance, and technologies that enable secure and responsible data sharing.
This event brings together leaders from FinTech, Health and Life Sciences to explore how cross-sector data ecosystems are creating new value streams, accelerating breakthroughs and improving outcomes.
With opening remarks from Level39 and Canary Wharf Group, the evening will feature a panel discussion followed by audience Q&A and networking with a highly engaged audience of founders, operators, investors and ecosystem leaders.
We’re also pleased to welcome Mike McMillan (CPRD), who will showcase the launch of CPRD Emulate, CPRD’s new synthetic data platform and MHRA government cost recovery service, demonstrating how synthetic health data can enable secure, privacy-first innovation.
Speakers
Mike McMillan – Business Development Team Leader, Clinical Practice Research Datalink (CPRD)
Experienced commercial leader in health data and digital innovation, Mike brings Director-level and CEO experience across public and private Health & Care markets. He leads business development at CPRD, driving new partnerships, products and services with a focus on data, AI and digital solutions that address significant unmet needs across research, regulation and healthcare innovation.
Catriona Campbell - Author | Speaker | Chair I AI 100, UK
Author and technologist with 20+ years’ experience in digital transformation and responsible AI, best-selling author of AI by Design, Chair of the Scottish AI Alliance, and MBE recipient for services to technology and innovation.
Michael Cook - Chief Science Officer, Our Future Health UK
CEO of IMU Biosciences, leading AI-driven immune profiling for precision medicine, with deep scientific and commercial leadership experience from Abcam, Bain & Company, and academic training at Cambridge and Oxford.
Adi Ben-Ari - Founder & CEO, Applied Blockchain
Founder of Applied Blockchain with over 20 years’ enterprise software experience, Adi is a recognised blockchain and cryptography thought leader, government advisor, and co-inventor of multiple patents in data privacy and confidential computing.
John Baker - CEO, IMU Biosciences
John leads AI-driven immune profiling for precision medicine, bringing senior biotech leadership experience from Abcam, Bain & Company, and a scientific background spanning Cambridge and Oxford.
Key themes
Data as a catalyst How shared data ecosystems can unlock innovation and competitive advantage
Cross-sector synergies
Real-world opportunities and examples of successful collaboration across finance, healthcare and life sciences
Governance & compliance Navigating regulation, ethics and trust in data sharing
Emerging technologies The role of AI, blockchain and secure data platforms in enabling trusted partnerships
Event format
5:30pm – 6:10pm Arrival & Networking
6:10pm – 6:15pm
Welcome & Opening Remarks
Level39 & Canary Wharf Group
6:15pm – 6:25pm
CPRD Emulate Showcase Mike McMillan, Business Development Team Leader, CPRD
6:25pm – 7:15pm
Panel Discussion & Audience Q&A
7:15pm - 8:00pm
Closing Remarks & Networking
Fin|Tech|Bio events consistently sell out - early registration is strongly recommended.